News for 'Department of Pharmaceuticals'

Blinken arrives in India; to discuss various issues with leaders

Blinken arrives in India; to discuss various issues with leaders

Rediff.com27 Jul 2021

Blinken and Indian leaders on Wednesday will discuss a plethora of pressing issues such as the fluid situation in Afghanistan, regional security concerns, COVID-19 response and ways to boost Indo-Pacific engagement, people familiar with the agenda of talks said.

Raids in ministries exposes racket of selling documents to corporates

Raids in ministries exposes racket of selling documents to corporates

Rediff.com12 Mar 2015

6 locations in New Delhi and 2 in Mumbai were raided.

HC wants govt control on crowdfunding for treatment of rare diseases

HC wants govt control on crowdfunding for treatment of rare diseases

Rediff.com9 Jul 2021

'I do not want every Tom, Dick and Harry to collect money. Is there any state control over this collection of funds via crowdfunding?'

Govt accepts Cairn's offer on retro tax

Govt accepts Cairn's offer on retro tax

Rediff.com18 Nov 2021

Moving quickly towards ending a retrospective tax dispute with a firm that gave India its largest oilfield, the government has accepted Cairn Energy PLC's undertakings which would allow for the refund of taxes, sources said. Meeting the requirements of the new legislation that scraps levy of retrospective taxation, the company had earlier this month given required undertakings indemnifying the Indian government against future claims as well as agreeing to drop any legal proceedings anywhere in the world. The government has now accepted this and issued Cairn a so-called Form-II, committing to refund the tax collected to enforce the retrospective tax demand, two sources with direct knowledge of the development said.

Trump warns India of retaliation if it doesn't allow export of drug

Trump warns India of retaliation if it doesn't allow export of drug

Rediff.com7 Apr 2020

The US president said that he has sought help from Prime Minister Narendra Modi to allow the sale of Hydroxychloroquine tablets ordered by the US to treat the growing number of coronavirus patients in his country, hours after India banned the export of the anti-malarial drug.

After April shock, drug sales improve in May

After April shock, drug sales improve in May

Rediff.com20 May 2020

The industry feels two factors have played a role in improving the offtake and reducing trade inventory - one is that the supply chain in pharmaceuticals has more or less stabilised, and secondly, with lockdown curbs easing and OPDs opening, some demand has grown at the consumer end as well.

Continuous efforts being made to ramp up vaccine supply: Modi

Continuous efforts being made to ramp up vaccine supply: Modi

Rediff.com18 May 2021

Describing state and district officials as 'field commanders' in the fight against COVID-19, Prime Minister Narendra Modi on Tuesday said localised containment zones, aggressive testing and sharing correct and complete information with people are weapons to defeat the pandemic.

India withdraws policy to cap nonessential pharma prices

India withdraws policy to cap nonessential pharma prices

Rediff.com23 Sep 2014

Ties between India and the United States have been strained in recent years because of trade policies and patent disputes.

Modi govt reshuffles top secretaries; Ajay Bhalla to be new home secy

Modi govt reshuffles top secretaries; Ajay Bhalla to be new home secy

Rediff.com24 Jul 2019

The appointments committee of the Cabinet headed by Prime Minister Narendra Modi cleared Bhalla's appointment as OSD in the ministry with immediate effect.

FDI norms may be eased to attract bidders for Air India

FDI norms may be eased to attract bidders for Air India

Rediff.com28 Oct 2019

In the aviation sector, 100 per cent FDI is allowed under automatic route for MRO (maintenance, repair, overhaul), ground handling, and aircraft purchase.

DoP seeks law ministry's opinion on drug pricing

DoP seeks law ministry's opinion on drug pricing

Rediff.com24 Oct 2012

Recently, Supreme Court asked the government not to alter the existing pricing mechanism for essential medicines.

National IPR Policy to be delayed further

National IPR Policy to be delayed further

Rediff.com28 May 2015

The draft is now with ministries.

Oxford Covid vaccine could be rolled out within 6 months: Report

Oxford Covid vaccine could be rolled out within 6 months: Report

Rediff.com3 Oct 2020

The UK government has ordered 100 million doses of the Oxford vaccine once it is ready for rollout and the doses are being manufactured before it has been shown to be successful in order to save time once it clears all the regulatory stages.

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Rediff.com21 Oct 2014

On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.

Police apprehend 2 men carrying Rs 27 lakh new notes

Police apprehend 2 men carrying Rs 27 lakh new notes

Rediff.com24 Nov 2016

On a tip-off from intelligence agencies, the Crime Branch team apprehended Ajit Pal Singh and Rajender Singh on Thursday evening, said a senior police officer.

Covid-19 leads to India's only quinine factory being revived

Covid-19 leads to India's only quinine factory being revived

Rediff.com17 Apr 2020

Perched in the hills of Darjeeling, the factory was set up in 1874, but has remained shut since 2001. Efforts to reopen the colonial era establishment are now on a war footing.

US: First batch of COVID-19 vaccine roll out of Pfizer plant

US: First batch of COVID-19 vaccine roll out of Pfizer plant

Rediff.com14 Dec 2020

The vaccine arrives at a critical moment for the US. Hospitalisations due to COVID-19 hit record highs for the seventh day in a row on Saturday.

Ranbaxy upbeat; US withdraws motion

Ranbaxy upbeat; US withdraws motion

Rediff.com8 Oct 2008

Pharmaceutical major Ranbaxy Labortaories on Wednesday said it remained confident that its products were safe and effective as the US Department of Justice (DoJ) withdrew a legal motion against it that charged fraudlent practice.

Lower India price tag may help drug MNCs

Lower India price tag may help drug MNCs

Rediff.com8 Nov 2008

A government committee that is looking into the possibility of pre-marketing price negotiation for patented medicines is likely to recommend a lenient view on such medicines, it is learnt. A government committee that is looking into the possibility of pre-marketing price negotiation for patented medicines is likely to recommend a lenient view on such medicines, it is learnt.

Govt not to reduce FDI cap in existing pharma companies

Govt not to reduce FDI cap in existing pharma companies

Rediff.com29 Nov 2013

Currently, 100 per cent FDI is permitted in brownfield pharma firms through clearance from the Foreign Investment Promotion Board.

NITI Aayog CEO to head panel on ecommerce FDI norms

NITI Aayog CEO to head panel on ecommerce FDI norms

Rediff.com10 Aug 2016

Representatives from four states including Maharashtra and Karnataka will also be members of the panel.

Centre waives off customs duty on oxygen, vaccines

Centre waives off customs duty on oxygen, vaccines

Rediff.com24 Apr 2021

This will boost availability of these items as well as make them cheaper, it said, adding that Modi also directed the revenue department to ensure seamless and quick custom clearance of such equipment.

Covid runs rampant in China as govt seems absent

Covid runs rampant in China as govt seems absent

Rediff.com26 Dec 2022

One Chinese source informed ANI that 10 million new infections are probably occurring daily in China.

Prices of 70 drugs may be raised

Prices of 70 drugs may be raised

Rediff.com28 Jul 2008

Move is the first in a series of steps to help pharma industry.

Covid-19 could be the boost Indian pharma cos need

Covid-19 could be the boost Indian pharma cos need

Rediff.com20 Sep 2020

The western world had largely considered India to be a production hub, and also, a good potential geography for clinical trials, and a big market. But in Covid-19 research, Indian companies and government researchers are also researching new drug candidates and potential vaccines, says Prosenjit Datta.

Medical device makers want higher import duty

Medical device makers want higher import duty

Rediff.com8 Feb 2010

While the manufacturers want higher Customs duty to make imports costlier and encourage the domestic industry, the department has called for a reduction in the duty to bring down the cost of imported devices.

Pharma R&D heads call the shots

Pharma R&D heads call the shots

Rediff.com13 Jun 2007

The average expenditure of pharmaceutical companies on research and development has increased four times in the last five years.

What does India export the most to China?

What does India export the most to China?

Rediff.com14 Jul 2020

Though the government has been pushing for exports of high-value manufactured goods across major markets in place of raw materials and input goods, India's top exports to China remain in the raw materials category.

Indian American to revamp New Jersey health care

Indian American to revamp New Jersey health care

Rediff.com16 Feb 2010

New Jersey Governor Chris Christie has named Dr Poonam Alaigh, director, Horizon Blue Cross Blue Shield, New Jersey, as the commissioner of the state Health and Senior Services Department, a cabinet post.Alaigh, 45, has a multifaceted background in health-care administration and delivery, including clinical practice, hospital practice, hospital administration, managed care, pharmaceutical medicine, and health-care policy.

NDA more eager to cap drug prices than UPA

NDA more eager to cap drug prices than UPA

Rediff.com14 Jan 2016

The impact from NELM on the Indian pharmaceutical sector is estimated to be around Rs 6,000 crore.

3 COVID vaccines under active consideration: Health ministry

3 COVID vaccines under active consideration: Health ministry

Rediff.com8 Dec 2020

Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmaceutical firm Bharat Biotech have applied to the Drugs Controller General of India seeking emergency use authorisation for their COVID-19 vaccines.

Patent drug pricing to distract from licences

Patent drug pricing to distract from licences

Rediff.com6 Mar 2013

The panel of representatives from various ministries and chaired by B K Singh, director, department of pharmaceuticals, has suggested the government negotiate prices of patented medicines based on reference prices of such drugs in other countries such as Britain, Canada, France, Australia and New Zealand.

Biden's 'mild shock' to Modi

Biden's 'mild shock' to Modi

Rediff.com29 Apr 2021

The trust some people in India had that the Biden-Harris administration would be friendly to India has been eroded already, observes Ambassador T P Sreenivasan.

Serum to produce up to 100 mn Covid vaccine doses for India, others

Serum to produce up to 100 mn Covid vaccine doses for India, others

Rediff.com7 Aug 2020

The company has set an affordable ceiling price of USD 3 (around Rs 225) per dose, it added.

11 killed after giant crane collapses at Visakhapatnam shipyard

11 killed after giant crane collapses at Visakhapatnam shipyard

Rediff.com1 Aug 2020

TV visuals showed the giant crane falling on the ground with a loud thud.

New drug pricing order challenged in court

New drug pricing order challenged in court

Rediff.com1 Aug 2013

The move is expected to delay the introduction of low-priced medicines in the market.

Major blow to Ranbaxy's American dream

Major blow to Ranbaxy's American dream

Rediff.com26 Jan 2012

Less than three months after roaring into us market with generic for cholesterol-reducing Lipitor, Dept of Justice files for permanent injunction against Ranbaxy.

FinMin not in favour of tightening FDI norms in pharma

FinMin not in favour of tightening FDI norms in pharma

Rediff.com15 Oct 2013

The Department of Industrial Policy and Promotion in its draft Cabinet has proposed to further tighten the rules for foreign direct investment in brownfield pharmaceutical sector.

Cairn officially withdraws cases to get Rs 7,900 cr tax refund

Cairn officially withdraws cases to get Rs 7,900 cr tax refund

Rediff.com3 Nov 2021

UK-based Cairn Energy PLC on Wednesday said it has agreed to drop litigations to seize Indian properties in countries ranging from France to the UK as it has accepted the Indian government's offer to settle tax dispute relating to the levy of taxes retrospectively. Meeting the requirements of new legislation that scraps levy of retrospective taxation, the company has given required undertakings indemnifying the Indian government against future claims as well as agreeing to drop any legal proceedings anywhere in the world. The government now has to accept this and issue Cairn a so-called Form-II, that will commit it to refund the tax collected to enforce the retrospective tax demand.